A POLYPILL INTERVENTION TO IMPROVE ADHERENCE FOR SECONDARY CARDIOVASCULAR DISEASE PREVENTION IN SPAIN: A COST-EFFECTIVENESS STUDY

被引：4
|
作者：
Arrabal, N. [1 ]
Kaskens, L. [1 ]
Garcia-Alonso, F. [1 ]
Gracia, A. [1 ]
机构：
[1] Ferrer Int, Barcelona, Spain
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.883
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV114
引用
收藏
页码：A393 / A393
页数：1
相关论文
共 50 条
  • [1] Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study
    Barrios, Vivencio
    Kaskens, Lisette
    Maria Castellano, Jose
    Cosin-Sales, Juan
    Emilio Ruiz, Jose
    Zsolt, Ilonka
    Fuster, Valentin
    Gracia, Alfredo
    REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (01): : 42 - 49
  • [2] Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain
    Gonzalez-Dominguez, A.
    Duran, A.
    Hidalgo-Vega, A.
    Barrios, V.
    REVISTA CLINICA ESPANOLA, 2023, 223 (07): : 414 - 422
  • [3] Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study
    Cordero, Alberto
    Gonzalez-Gallarza, Regina Dalmau
    Masana, Lluis
    Fuster, Valentin
    Castellano, Jose Ma
    Olivar, Jose Emilio Ruiz
    Zsolt, Ilonka
    Sicras-Mainar, Antoni
    Juanatey, Jose Ramon Gonzalez
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 559 - 571
  • [4] Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
    Kohli-Lynch, Ciaran N.
    Moran, Andrew E.
    Kazi, Dhruv S.
    Bibbins-Domingo, Kirsten
    Jordan, Neil
    French, Dustin
    Zhang, Yiyi
    Wang, Thomas J.
    Bellows, Brandon K.
    JAMA CARDIOLOGY, 2025, 10 (03) : 224 - 233
  • [5] Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK
    Becerra, Virginia
    Gracia, Alfredo
    Desai, Kamal
    Abogunrin, Seye
    Brand, Sarah
    Chapman, Ruth
    Garcia Alonso, Fernando
    Fuster, Valentin
    Sanz, Gines
    BMJ OPEN, 2015, 5 (05):
  • [6] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    BMJ OPEN, 2011, 1 (02):
  • [7] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    HEART, 2017, 103 (07) : 491 - 499
  • [8] THE POLYPILL IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: COST-EFFECTIVENESS IN THE DUTCH POPULATION
    Van Gils, P. F.
    Hamberg-Van Reenen, H. H.
    Over, E.
    de Wit, G. A.
    van den Berg, M.
    Schuit, A. J.
    Engelfriet, P. M.
    VALUE IN HEALTH, 2011, 14 (07) : A381 - A381
  • [9] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [10] Cost-effectiveness of cardiovascular prevention programs in Spain
    Plans-Rubio, P
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (02) : 320 - 330
12345